• EPH55 The Prevalence of Obesity and Its Implications in China: A Narrative Review of Literature

    Dec 1, 2022, 00:00

  • EE178 Cost-of-Illness Analysis of Pertussis Among Adults 50 Years of Age and Older in the United Kingdom

    Dec 1, 2022, 00:00

  • SA64 Management of the Post-Surgery Hospital Care in France According to the Type of Surgery: A French Claims Database Analysis

    Dec 1, 2022, 00:00

  • MT17 The Value of Next Generation Sequencing for Lung Cancer in Europe: Findings From a Literature Review

    Dec 1, 2022, 00:00

  • EE217 Population Genomic Screening for Tier 1 Genomic Applications: A Cost-Effectiveness Analysis

    Dec 1, 2022, 00:00

  • SA22 Examination of Correlations Between Core Stability, Low Back Pain and Stress in the Staff of the Hungarian National Ambulance Service

    Dec 1, 2022, 00:00

  • EPH146 Inequitable Access to Cannabis Vaping Products Across Canada: Examining Consumer Preferences

    Dec 1, 2022, 00:00

  • EE434 Health Care Resource Use and Costs in Transthyretin Amyloid Cardiomyopathy - A Swedish Medical Record Review Study

    Dec 1, 2022, 00:00

  • PCR255 The EQ Health and Wellbeing (EQ-HWB) and the Eq Health and Wellbeing Short (EQ-HWB-S) as an Outcome Measure in Mental Health and Well-Being: A Comparison to the EQ-5D-5L, EQ-5D-3L and the Short Warwick-Edinburgh Mental Well-Being Sca ...

    Dec 1, 2022, 00:00

  • CO145 Sensitivity to Change of the PDQ-Exercise

    Dec 1, 2022, 00:00

  • PCR127 Impact of Dry Eye on Daily Life and Patient Satisfaction Using Eye Drops. Psychometrics Properties of a New Scale

    Dec 1, 2022, 00:00

  • HPR128 Suitability of Nordic Real-World Data to Support US Regulatory Decision-Making

    Dec 1, 2022, 00:00

  • EE303 Distribution and Predictors of Haemophilia-Related Direct Medical Cost in the United Kingdom: Analysis of Data From the CHESS I and CHESS II Burden of Illness Studies

    Dec 1, 2022, 00:00

  • MSR36 Modelling of UK General Population Utility: The ALDVMM Approach in Practice

    Dec 1, 2022, 00:00

  • RWD144 Real World Data (RWD) Sharing Internationally: Case Digital Twin (DT) in Inflammatory Bowel Disease (IBD)

    Dec 1, 2022, 00:00

  • HSD113 Reducing Antibiotic Misuse Through the Use of Point-of-Care Tests in Germany – A Multicenter Study

    Dec 1, 2022, 00:00

  • HTA184 Investigating How Orphan Drug Manufacturers Can Optimize Clinical Trial Design so Patients across Geographies Can Access Life-Saving Innovations

    Dec 1, 2022, 00:00

  • HTA116 How is Carer Quality of Life Included in Health Technology Assessment Globally? A Review of Guidance, With Case Studies and Recommendations

    Dec 1, 2022, 00:00

  • EE310 Cost-Effectiveness of the Prenatal Detection of Congenital Heart Diseases: A Systematic Literature Review

    Dec 1, 2022, 00:00

  • RWD139 Impact of the COVID-19 Pandemic on Diagnosis and Cancer-Related Medical Procedures in Brazil

    Dec 1, 2022, 00:00

  • CO41 Systematic Literature Review of the Survival, Humanistic and Economic Impact of Systemic Corticosteroid Use

    Dec 1, 2022, 00:00

  • EE443 Economic Value of Covered Expanded Polytetrafluoroethylene (eptfe) Stent Grafts Compared to Percutaneous Balloon Angioplasty for Treating Thrombosed and Dysfunctional Arteriovenous Grafts in Hemodialysis Patients in Spain

    Dec 1, 2022, 00:00

  • P46 How Are European Countries Assessing Digital Health Technologies (DHTS)? A Comparison of DHT Health Technology Assessments (HTAS) Across France, Germany and the UK

    Dec 1, 2022, 00:00

  • EPH21 Obesity, a Public Health Threat in Gree Its Contribution to Future Cardiovascular Disease Burden

    Dec 1, 2022, 00:00

  • HSD109 Predictors of Saudi Arabian Pharmacists’ Intent to Provide Medication Counselling

    Dec 1, 2022, 00:00

  • EE398 Budget Impact Analysis of Lurasidone in the Treatment of Adult and Adolescent Patients With Schizophrenia in Spain

    Dec 1, 2022, 00:00

  • EE115 Cost-Effectiveness and Cost-Utility Analyses of Polatuzumab Vedotin With Rituximab and Chemotherapy vs Rituximab and Chemotherapy in Treating Naïve Diffuse Large B-Cell Lymphoma in Italy

    Dec 1, 2022, 00:00

  • PCR222 Quality of Life (QOL) in Patients With Depression– A Review of Patient Reported Outcomes Instruments

    Dec 1, 2022, 00:00

  • MT4 Study Design Recommendations in ISO Standards for High-Risk Medical Devices: A Systematic Review of the HORIZON2020 Core-MD Project

    Dec 1, 2022, 00:00

  • EE531 Cost-Utility Analysis of Once-Weekly Semaglutide Versus Dulaglutide in Patients With Type 2 Diabetes Requiring Treatment With a GLP-1 Receptor Agonist

    Dec 1, 2022, 00:00

  • EPH34 Long COVID Symptoms and Diagnosis in Primary Care: A Cohort Study Using the Thin Database Including Unstructured Text

    Dec 1, 2022, 00:00

  • EE480 Cost-Effectiveness of Empagliflozin for the Treatment of Patients With Heart Failure With Above 40% Ejection Fraction in England

    Dec 1, 2022, 00:00

  • EE425 Economic Modeling of Web Embolization vs Coiling vs Stent-Assisted Coiling for the Endovascular Treatment of Unruptured Intracranial Aneurysms

    Dec 1, 2022, 00:00

  • PCR219 Women's Knowledge About Breast Cancer Screening in Hungary

    Dec 1, 2022, 00:00

  • HPR131 Benefit Package of Universal Coverage Scheme for Hereditary Angioedema (HAE) Caused by C1 Esterase Inhibitor Deficiency (C1-INH)

    Dec 1, 2022, 00:00

  • MSR111 Methodology for Building Physician Target List Using Claims and EHR Data

    Dec 1, 2022, 00:00

  • HTA97 Impact of Additive PICOs in a European Joint Health Technology Assessment. a Hypothetical Case Study in Lung Cancer

    Dec 1, 2022, 00:00

  • MT12 A Targeted Literature Review on Digital Health Innovation (DHI) in Asia Pacific (APAC) Region

    Dec 1, 2022, 00:00

  • EE668 Empagliflozin for the Treatment of Adult Patients With Symptomatic Chronic Heart Failure With Reduced Ejection Fraction (HFREF): A Cost-Effectiveness Analysis From the Italian NHS Perspective

    Dec 1, 2022, 00:00

  • HPR202 Use of Real-World Data in Regulatory and Reimbursement Submissions for Personalized Medicines in Europe

    Dec 1, 2022, 00:00

  • HTA250 Health Technology Assessment Policy and Guideline Changes in the EU-5 During the COVID-19 Pandemic Era: An Insight Into Trends and Drivers

    Dec 1, 2022, 00:00

  • EE547 Cost-Effectiveness Analysis of Rituximab for Chronic Lymphocytic Leukemia Using a Semi-Markovian Model Approach in R

    Dec 1, 2022, 00:00

  • EE648 Economic Analysis of New Single-Inhaler Triple Therapies in Patients With COPD in the UK

    Dec 1, 2022, 00:00

  • HTA161 A Systematic Review of the Safety of COVID-19 Anti-Interleukin Therapy

    Dec 1, 2022, 00:00

  • HPR152 Impact of Brexit-Induced Changes to Regulatory Approval on UK Access to Medicines

    Dec 1, 2022, 00:00

  • PCR33 Health State Utilities for Woman With Breast Cancer in Portugal

    Dec 1, 2022, 00:00

  • EE662 Cost-Effectiveness of Iron Chelation Therapies for the Treatment of Transfusional Iron Overload in Β-Thalassaemia, Sickle Cell Disease, and Myelodysplastic Syndrome: A Literature Review

    Dec 1, 2022, 00:00

  • EE394 Cost-Effectiveness of Alpelisib Plus Fulvestrant for the Treatment of Postmenopausal Women With PIK3CA Mutant, HR+/HER2- Advanced Breast Cancer in Turkey

    Dec 1, 2022, 00:00

  • PCR109 Optimism, Social Support and Psychosocial Impact Among Breast Cancer Survivors: The Mediating Effect of Resilience

    Dec 1, 2022, 00:00

  • EE551 Cost Benefits of Ibuprofen Ready to Use Solution Versus IV Drugs in Postoperative Analgesia

    Dec 1, 2022, 00:00

  • HSD6 Developing a Risk-Stratification Dashboard Based in Artificial Intelligence (AI) to Identify Patients for a Model of Health Care: A Population-Based Cohort Study in Brazil

    Dec 1, 2022, 00:00

  • HPR113 Health Metrics and Theories of Health Value

    Dec 1, 2022, 00:00

  • EE158 Economic Burden of Cervical Cancer in Bulgaria

    Dec 1, 2022, 00:00

  • PCR284 Fatigue and Health-Related Quality of Life in Paroxysmal Nocturnal Haemoglobinuria (PNH): A Post-Hoc Analysis of Pegcetacoplan Pegasus Facit-Fatigue Trial Data

    Dec 1, 2022, 00:00

  • SA23 Application of Meta-Analysis Approach to Develop an External Control Arm in Oncology and Rare Diseases: Insights From Real-World Evidence

    Dec 1, 2022, 00:00

  • EE452 Cost-Effectiveness Analysis of Introducing Ceftazidime-Avibactam to Treatment Strategies for Hospital-Acquired Infections in Greece

    Dec 1, 2022, 00:00

  • HPR36 Evaluating Patient Preference Information in Regulatory Decision-Making

    Dec 1, 2022, 00:00

  • EE449 Cost-Effectiveness of One Session Treatment (OST) for Children and Young People With Specific Phobias Compared to Multi-Session Cognitive Behavioural Therapy (CBT): Results From a Randomised Controlled Trial

    Dec 1, 2022, 00:00

  • HTA3 The Clinical and Economic Value of a Sustained Response in the Treatment of Moderate-to-Severe Psoriasis in Spain: The PSOVALUE Project

    Dec 1, 2022, 00:00

  • EPH208 Acquired Hemophilia A (AHA) – Trends in Frequency and Treatment Patterns in Germany

    Dec 1, 2022, 00:00

  • SA1 The Use of Multi-Criteria Decision Analysis (MCDA) to Support Decision-Making in Healthcare: An Updated Systematic Literature Review

    Dec 1, 2022, 00:00

  • RWD158 A Systematic Literature Review (SLR) of Clinical Practice Guidelines (CPGS) and Real-World Treatment Patterns in Metastatic Gastrointestinal Stromal Tumours (MGISTS) in Europe

    Dec 1, 2022, 00:00

  • HTA33 Does the Selection of Participating Regions Impact the Outcome of Spanish Therapeutic Positioning Reports?

    Dec 1, 2022, 00:00

  • EE284 Cost-Effectiveness of Pembrolizumab in Combination With Chemotherapy As First-Line Treatment of Advanced or Metastatic Esophageal Cancer or HER2-Negative Gastroesophageal Junction Adenocarcinoma in France

    Dec 1, 2022, 00:00

  • EPH111 Causes of Medication Administration Errors in a University Hospital in Brazil

    Dec 1, 2022, 00:00

  • EE508 Work Productivity Loss Among Women With Menopausal Symptoms: A Systematic Literature Review

    Dec 1, 2022, 00:00

  • EPH100 Ergonomic Benefits of 3D Visualization for Ophthalmic Surgeons

    Dec 1, 2022, 00:00

  • CO64 Comparison of Propensity Score Matching to Inverse Probability Weighting in Obstructive Sleep Apnea Patients With Cardiovascular Diseases

    Dec 1, 2022, 00:00

  • SA79 Association Between Antibiotic Exposure and Survival Among Patients Diagnosed With Advanced Melanoma or Advanced Non-Small Cell Lung Cancer (NSCLC) Treated With Immune Checkpoint Inhibitor (ICI) Therapy

    Dec 1, 2022, 00:00

  • PCR151 Acceptability, Reliability, and Inconsistency in an Analytic Hierarchy Process-Survey With People Living With Dementia and Physicians: Analyses From the PreDemCare-Study

    Dec 1, 2022, 00:00

  • HPR138 Comparing and Contrasting Early Access Opportunities Across the EU4 and UK

    Dec 1, 2022, 00:00

  • MSR66 Approaches to Control for Observable Selection Bias in Studies Including Staggered Treatment Timing

    Dec 1, 2022, 00:00

  • HPR45 Medical Quality Indicators Trends During the Coronavirus Pandemic in Israel: Meuhedet Health Services Real Data Analysis and Future Conclusions

    Dec 1, 2022, 00:00

  • EPH147 A Joinpoint Regression Analysis of Food Supply Trends — Comparing Hungary to OECD Average

    Dec 1, 2022, 00:00

  • HTA88 Similarities and Differences in Scientific Advice Processes

    Dec 1, 2022, 00:00

  • EE439 Budgetary Impact of PCV20 Use Among Privately Insured Adult Patients Living in Dubai Who Are at Elevated Risk of Pneumococcal Disease

    Dec 1, 2022, 00:00

  • CO161 Comparison of Clinical Outcomes in De Novo Versus Relapsed/Progressed Advanced Non-Small Cell Lung Cancer Patients Without EGFR Mutations or ALK Rearrangements

    Dec 1, 2022, 00:00

  • EPH79 Examining the Health Behaviour of Young People

    Dec 1, 2022, 00:00

  • EE75 Cost-Effectiveness of Heart Failure Treatments– A Targeted Literature Review

    Dec 1, 2022, 00:00

  • CO169 Assessing Parameters and Microbiological Factors Affecting Phlebitis Associated With Peripheral Cannulas

    Dec 1, 2022, 00:00

  • HTA181 Cost-Utility Evaluation of Mammography Screening Program in Taiwan: Considering Costs Related to False Positive Results

    Dec 1, 2022, 00:00

  • EE441 Health Economic Model for Estimating the Direct Cost Impact of Adopting an Antimicrobial Vascular Access Site Dressing in Oncology Patients With Central Venous Catheter in the UK

    Dec 1, 2022, 00:00

  • SA4 Effectiveness of Injury Prevention Primary Prevention Movement Program Among Handball Players

    Dec 1, 2022, 00:00

  • PCR261 Elicitation of Health Utilities Online in Patients With Spinal Muscular Atrophy

    Dec 1, 2022, 00:00

  • HTA20 Safety and Cost Analysis of Image-Guided Functional Endoscopic Sinus Surgery in China

    Dec 1, 2022, 00:00

  • HTA12 Outpatient Medicine Reimbursement in Sweden: An Analysis of TLV Decisions Between 2016 and 2022

    Dec 1, 2022, 00:00

  • CO140 Costs and Healthcare Resource Utilization Among Patients With Lean Non-Alcoholic Steatohepatitis (NASH) Using Real-World Data (RWD)

    Dec 1, 2022, 00:00

  • HTA189 Implications of the French Temporary Authorisation for Use Reform for the Pharma Industry

    Dec 1, 2022, 00:00

  • OP18 Applicability of Appraisal Tools of Real-World Evidence in Health Technology Assessment: A Literature Review and Content Analysis

    Dec 1, 2022, 00:00

  • RWD72 Real-World Treatment Pathways of Patients With Diffuse Large B-Cell Lymphoma Receiving Second Line Treatment or Later in the UK, Canada, France, Germany, Italy, and Spain: A Prospective Survey of Physicians

    Dec 1, 2022, 00:00

  • EPH137 CAR-T Cell Therapy: The State-of-the-Art of Evidence and Barriers in a Real-World Setting

    Dec 1, 2022, 00:00

  • PCR162 Patient and Physician Perspectives Towards Current HIV Treatment Satisfaction and the Use of Long-Acting Injectable Therapy for HIV in Taiwan

    Dec 1, 2022, 00:00

  • HTA216 Assessment of Key Drivers of Economic Evaluations for Digital Health and Medical Technologies: Insights and Lessons From Review of NICE Medical Technology Assessment Reports (2010-2022)

    Dec 1, 2022, 00:00

  • HTA133 Comparing the Lifetime Survival in Patients With Early-Stage Hepatocellular Carcinoma Receiving Two Competitive Treatments: Liver Transplantation Versus Hepatic Resection

    Dec 1, 2022, 00:00

  • RWD24 Assessing the Performance of Propensity Score Methods in Balancing Unobservable Confounders: Evidence From Linked Data in Multiple Sclerosis

    Dec 1, 2022, 00:00

  • MT8 A Systematic Literature Review of Published Economic Evaluations for Medical Devices in Cardiovascular Disease

    Dec 1, 2022, 00:00

  • SA18 Development and Application of a Taxonomy on the Beneficial Effects of Oral Anticoagulant Switching in Atrial Fibrillation

    Dec 1, 2022, 00:00

  • CO91 Investigation of Conceptual Distinction Between Response Set Options - A Step Toward Obtaining Quality Data

    Dec 1, 2022, 00:00

  • MT40 Trends in Clinical Evidence for Digital Health Applications (DiGa) Reimbursed in the German DiGa Directory

    Dec 1, 2022, 00:00

  • RWD90 Chart Review Study for Patients With Sickle Cell Disease With Central Nervous System Crises in Jazan – Saudi Arabia

    Dec 1, 2022, 00:00

  • CO47 Medical and Non-Medical Reasons for Discontinuation of Anti-TNF Agents Among Patients With Ulcerative Colitis in Real-World Setting: A Systematic Review

    Dec 1, 2022, 00:00

  • EE638 Consumption of Stoma Appliances and Supporting Products Among Persons Living With a Stoma: A Swedish Register Study

    Dec 1, 2022, 00:00

  • MT41 Process and Requirements for Submitting Nonpharmaceutical Medical Technologies to Health Technology Assessment Authorities

    Dec 1, 2022, 00:00

  • HSD96 Burden of Patient Journey in the Management of Alpha-1 Antitrypsin Deficiency in Spain

    Dec 1, 2022, 00:00

  • CO22 Use of Ixekizumab for Psoriatic Arthritis Patients in Real-World Conditions

    Dec 1, 2022, 00:00

  • MSR124 Development of a Machine Learning Predictive Model for Stroke Among Patients With Non-Valvular Atrial Fibrillation Receiving Oral Anticoagulant Treatment

    Dec 1, 2022, 00:00

  • PCR53 Patient Experiences Before and After Enfortumab Vedotin Neoadjuvant Treatment in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

    Dec 1, 2022, 00:00

  • EE211 Shadow Costs of Systemic Corticosteroid-Related Adverse Events in Ulcerative Colitis: A Pharmacoeconomic Evaluation

    Dec 1, 2022, 00:00

  • CO116 Cardiovascular Safety of Glimepiride: An Indirect Treatment Comparison of Cardiovascular Safety Outcome Trials of DPP4 Inhibitors

    Dec 1, 2022, 00:00

  • Cover

    Dec 1, 2022, 00:00

  • SA60 Seeking ISPOR Abstracts: Is Searching Embase Enough?

    Dec 1, 2022, 00:00

  • MSR25 To Merge Randomized Controlled Trials and Real-World Evidence With Bayesian Network Meta-Regression: A Case Study in Patients With Myelodysplastic Syndromes

    Dec 1, 2022, 00:00

  • EPH90 The 2010 HIV Outbreak Among People Who Inject Drugs in Athens, Greece Could Have Been Prevented If the 2009 Undetected HCV Outbreak Had Been Detected. What Would Have Been the Savings If There Was an Outbreak Detection System?

    Dec 1, 2022, 00:00

  • EE169 Estimation of Value of Life for Turkiye With a Model Approach Depending on Net Present Value

    Dec 1, 2022, 00:00

  • SA78 Agile Review of the Literature Using a Structured, Non-Systematic Approach: Example Application for a Genomic Diversity Question

    Dec 1, 2022, 00:00

  • Deciding Between SF-6Dv2 Health States: A Think-Aloud Study of Decision-Making Strategies Used in Discrete Choice Experiments

    Dec 1, 2022, 00:00

  • EE118 Capturing Patient Value in an Economic Evaluation

    Dec 1, 2022, 00:00

  • P32 The Use of 'Placebo Adjusted Risk Difference Network Meta-Analysis' to Account for Confounding by Heterogeneity in Placebo Response Across Studies

    Dec 1, 2022, 00:00

  • PCR143 Project Hercules - Burden of Steroid Use in the Treatment of Duchenne Muscular Dystrophy: Findings From Patient and Carer Dyads and a Focus Group

    Dec 1, 2022, 00:00

  • MT23 Use of Real Time Chat Functionality in Decentralized Clinical Trials

    Dec 1, 2022, 00:00

  • PCR3 Assessing Concept Saturation and Sample Representativeness When Using Social Media Data to Inform Concept Elicitation Studies

    Dec 1, 2022, 00:00

  • EE39 Willingness to Pay for Cancer Prevention, Screening, Diagnosis, and Treatment: A Systematic Review

    Dec 1, 2022, 00:00

  • CO172 Physical Activity and Health-Related Quality of Life of Patients With Chronic Pain After Total Knee Replacement: Evidence From a Physiotherapy Randomised Controlled Trial

    Dec 1, 2022, 00:00

  • EE609 The Cost of Beta Thalassemia Major Disease From Patient Perspective in Egypt

    Dec 1, 2022, 00:00

  • HTA203 Methods Used for Trend Estimation of Epidemiological Figures in the German Benefit Assessment (AMNOG) Process

    Dec 1, 2022, 00:00

  • HSD80 Corporate Environmental and Social Responsibility Applied in a Technical Service Network: Addressing Greener Business, Employee Customer Satisfaction

    Dec 1, 2022, 00:00

  • EE160 Budget Impact Analysis for Point of Care Testing (POCT) in Diabetic Patient Monitoring: The Experience of an Italian Local Health Board (ASL3 Genoa, Italy)

    Dec 1, 2022, 00:00

  • EE230 Clinical and Economic Outcomes Associated With Use of Anti-Arrhythmic Drugs Versus Ablation in Atrial Fibrillation (AFib)

    Dec 1, 2022, 00:00

  • RWD31 Secure Processing Environments (SPE) Are Needed for the Cybersecure Collection and Secondary Use of Personal, Health, and Social Data

    Dec 1, 2022, 00:00

  • PCR254 Targeted Literature Review of Caregiver Burden and Generational Burden in Depression

    Dec 1, 2022, 00:00

  • RWD17 A Retrospective Observational Study on the Healthcare Resource Use of Patients With Myasthenia Gravis in Secondary Care in England Using Hospital Episodes Statistics

    Dec 1, 2022, 00:00

  • HTA14 Health Economic Evaluation of Nation-Wide Screening Programmes for Atrial Fibrillation in the Netherlands

    Dec 1, 2022, 00:00

  • EE607 Healthcare Utilisation of Patients With Eosinophilic Granulomatosis With Polyangiitis (EGPA): A European Perspective

    Dec 1, 2022, 00:00

  • PCR135 Symptom Burden and Its Impact on Daily Living with Idiopathic Multicentric Castleman’s Disease: Development and Psychometric Validation of a Bespoke International Patient and Caregiver Survey

    Dec 1, 2022, 00:00

  • EE322 Public Health Impact and Return on Investment of the Pediatric Immunization Program in Poland

    Dec 1, 2022, 00:00

  • EPH2 Development and Validation of Clinical Prediction Score of Mortality in Tuberculosis Patients

    Dec 1, 2022, 00:00

  • EE493 Cost-Effectiveness of Pembrolizumab+Lenvatinib for Treatment of Advanced Endometrial Carcinoma in Women Who Have Progressed Following Prior Systematic Therapy and Are Not Candidates for Curative Surgery or Radiation in France

    Dec 1, 2022, 00:00

  • EE267 Evolution of Country Gross Domestic Product Following the COVID-19 Pandemic

    Dec 1, 2022, 00:00

  • PCR30 An Empirical Comparison of EQ-5D-Y-5L and EQ-5D-Y 3L Questionnaires

    Dec 1, 2022, 00:00

  • HTA57 Recommendations for Evidence Generation Activities Supportive of National HTA in the South African Public Health Sector

    Dec 1, 2022, 00:00

  • HSD71 Convergent and Known-Group Validity of the Start Musculoskeletal Tool Among Patients with Neck Pain

    Dec 1, 2022, 00:00

  • PCR138 Association of SARS-CoV-2 Omicron Ba.1 on Adherence to Oral Tetrabenazine Congener and Quality of Life of Patients Diagnosed With Huntington's Disease With Chorea or Tardive Dyskinesia on the Service of a USA Specialty Pharmacy

    Dec 1, 2022, 00:00

  • EE175 Budget Impact Assessment of Knee Orthoses Funding in Patients With Osteoarthritis of the Knee Considering Total Knee Reconstructive Surgery: Private Australian Payer Perspective

    Dec 1, 2022, 00:00

  • HPR37 Comparing Reimbursement of New Drugs During the COVID-19 Pandemic in Ireland and Scotland

    Dec 1, 2022, 00:00

  • SA26 Win Ratio Analyses of Multiple Endpoints in Rare Disease Trials: A Case-Study Based on a Trial of Avaglucosidase Alfa in Late-Onset Pompe Disease (LOPD)

    Dec 1, 2022, 00:00

  • HPR52 TNF-Alfa Inhibitor Therapies: Evaluating the Impact of Biosimilars Competition in Italy, Portugal and Spain

    Dec 1, 2022, 00:00

  • RWD107 Better Use of Real-World Data Through Predictive Analytics: A Knowledge-to-Wisdom Conceptual Framework for Evidence-Based Practice

    Dec 1, 2022, 00:00

  • PCR123 Assessment of Drug-Drug Interactions in Criticalcare Unit of a Tertiary Care Hospital

    Dec 1, 2022, 00:00

  • HPR162 Analysis of Intra-Regional Variability of Drugs’ Time to Access in Italy

    Dec 1, 2022, 00:00

  • MSR116 Multivariate Associations between Health Outcomes and Health System Performance Indicators: An Integrated Factor Analysis with Canonical Correlations

    Dec 1, 2022, 00:00

  • PCR121 Do Changes in Patient-Reported Outcomes Predict Overall Survival in Patients With Diffuse Large B-Cell Lymphoma?

    Dec 1, 2022, 00:00

  • PCR227 Psoriasis and Alterations in Quality of Life at Work: A Study Cross-Referencing Real-World Data From Two Sources—Medical Consultations and Social Networks

    Dec 1, 2022, 00:00

  • RWD48 Introduction to Odyssey: Real-World Rare Disease Data Collection Program From Digitized Health Records of Patients With Glycogen Storage Disease Type III (GSDIII) in the United States

    Dec 1, 2022, 00:00

  • HSD116 Bullous Pemphigoid Disease Activity and Initiation of Systemic Therapy in the Real-World Setting

    Dec 1, 2022, 00:00

  • RWD143 Synthetic Health Data at a Glan Striking a Balance between Privacy and Utility

    Dec 1, 2022, 00:00

  • EE186 Assessment of the Cost-Effectiveness of Secukinumab Versus Risankizumab for the Treatment of Adults With Moderate-to-Severe Plaque Psoriasis in the UK

    Dec 1, 2022, 00:00

  • CO49 3D Visualisation Systems: Advantages for Cataract Surgery

    Dec 1, 2022, 00:00

  • EE414 Cost-Effectiveness of Mobile Intermittent Pneumatic Compression Devices (IPCD) Compared to Traditional IPCD for Early Postoperative Total Knee Replacement: The Hospital’s Perspectives

    Dec 1, 2022, 00:00

  • CO106 Impact of Phase Angle in Quality of Life and Mortality in Male With Head and Neck Cancer

    Dec 1, 2022, 00:00

  • EPH3 Could We Continue CXR Screening for Lung Cancer: Re-Evaluation of CXR Screening With Background Consideration

    Dec 1, 2022, 00:00

  • HPR163 Joint Scientific Consultation (JSC) and Joint Clinical Assessment (JCA) - A Better Road to Access?

    Dec 1, 2022, 00:00

  • COVIDnomics

    Dec 1, 2022, 00:00

  • RWD128 Exploring the Burden of COVID-19 on Post-Traumatic Stress Disorder (PTSD) in Pre- and During-COVID-19 Pandemic Using Real-World Data

    Dec 1, 2022, 00:00

  • EE369 Cost-Effectiveness Analysis of Drug Therapies for Diabetes Mellitus Type 2 in Chile

    Dec 1, 2022, 00:00

  • MSR63 Barriers to Improving the Digital Performance of the Pharmaceutical Industry

    Dec 1, 2022, 00:00

  • EE611 A Cost-Minimization and Budget Impact Analysis to Evaluate the Introduction of an Acellular Hexavalent Vaccination for Pediatric Population in Dominican Republic

    Dec 1, 2022, 00:00

  • EE445 Treatment Costs of Comorbidities in Patients With Peripheral Artery Disease in Turkiye

    Dec 1, 2022, 00:00

  • HSD87 Exploring the Treatment Patterns of Bipolar Disorder Using the Observational Medical Outcomes Partnership Common Data Model

    Dec 1, 2022, 00:00

  • HPR85 Opportunities of Innovative Agreements for Pricing Advanced Therapy Medicine Products (ATPM) in Brazil

    Dec 1, 2022, 00:00

  • SA57 Differences in Low Back Pain Knowledge Between Cultures: The Instance of Chinese and Hungarian Adults

    Dec 1, 2022, 00:00

  • CO150 Characteristics, Healthcare Resource Utilization and Costs Among Medicaid-Insured Adults With Hepatitis Delta Virus: An Analysis of US All-Payer Medical and Pharmacy Claims Data

    Dec 1, 2022, 00:00

  • HSD57 The Actionable Gaps of the Journey of Patients With Lung Cancer

    Dec 1, 2022, 00:00

  • MSR75 Publication Trends of Network Meta-Analyses in Europe and Asia: A Focus on Cardiovascular Disease

    Dec 1, 2022, 00:00

  • PCR98 Cultural Adaptation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) into Spanish

    Dec 1, 2022, 00:00

  • EE304 Cost-Effectiveness of Volume Computed Tomography in Lung Cancer Screening: A Cohort Simulation Based on Nelson Study Outcomes

    Dec 1, 2022, 00:00

  • EE388 Cost Effectiveness of Novel Antibiotic Ceftolozane/Tazobactam in Patients With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia in Greece

    Dec 1, 2022, 00:00

  • EPH150 The Psychological Impacts of COVID -19 as a Social Influence Parameter During the Pandemic

    Dec 1, 2022, 00:00

  • EE670 Using an Efficiency Frontier Approach to Generate Value Bases Price Estimates for a Transformational TPP

    Dec 1, 2022, 00:00

  • EE511 Cost Effectiveness of Uroprotective Agents for Cyclophosphamide and Ifosfamide Induced Hemorrhagic Cystitis in Childhood Cancers

    Dec 1, 2022, 00:00

  • HPR21 Project Orbis the UK: 18-Month Report Card – Implications of UK Market Access for Oncology Drugs Prior to Europe

    Dec 1, 2022, 00:00

  • PCR248 The Value of Clinical Functions in Neurorehabilitation - Can a Value Function Be Derived From a Generic Instrument?

    Dec 1, 2022, 00:00

  • PCR128 Patient-Reported Symptoms Are the Sole Independent Predictor of the Societal Burden Associated With Inflammatory Bowel Disease: A Cross-Sectional Study

    Dec 1, 2022, 00:00

  • EE266 A Review on the Economic Evaluation of Infertility Pharmacologic Agents in North America and European Countries

    Dec 1, 2022, 00:00

  • HPR194 The UK Innovative Licensing and Access Pathway (ILAP) Program – Early Trends in Innovation Passport Awards

    Dec 1, 2022, 00:00

  • MSR103 Comparison of Three Indirect Overall Survival (OS) Modeling Approaches in Predicting Long-Term OS Benefit in Randomized Controlled Trials: A Case Study From the Relativity-047 Study

    Dec 1, 2022, 00:00

  • HTA104 Opportunities to Improve the Adoption of Quality of Life Data as Part of the French Health Technology Assessment Process

    Dec 1, 2022, 00:00

  • HPR200 The Impact of Community Pharmacies on Regional Equity in Access to Professional Rapid Antigen Testing for SARS-COV-2 in Portugal

    Dec 1, 2022, 00:00

  • EE299 Cost-Effectiveness of Left Ventricular Assist Devices (LVAD) as Destination Therapy: A Systematic Review

    Dec 1, 2022, 00:00

  • HTA254 Roadblocks to Effective Patient Engagement in Health Technology Assessment in Europe: A Review of Patient-Perceived Challenges

    Dec 1, 2022, 00:00

  • PCR34 Demographic Analysis of Cancer Patients Who Voluntarily Used a Digital Health Tool to Self-Report Medications, Symptoms and Well-Being

    Dec 1, 2022, 00:00

  • EE620 A Meta-Analysis of Bronchoscope Associated Cross-Infection and Early Cost-Effectiveness Analysis of Single-Use Compared to Reusable Flexible Bronchoscopes in the Bronchoscopy Suite of American Academic Institutions

    Dec 1, 2022, 00:00

  • HTA265 Perspectives of National Health-Related Quality of Life Measurement Implementation in Ukraine

    Dec 1, 2022, 00:00

  • PCR26 Assessing the Content Validity of Preference-Based Measures in Cancer

    Dec 1, 2022, 00:00

  • RWD93 The Experience of Cancer Cooperative Groups With Real-World Data Research: Insights From an EORTC Survey

    Dec 1, 2022, 00:00

  • EE60 An Economic Evaluation of Introducing Ferric Carboxymaltose for the Treatment of Iron Deficiency in Patients With Heart Failure From the Perspective of Healthcare Payers in Sweden, Germany, France, Poland and Spain

    Dec 1, 2022, 00:00

  • RWD102 Electronic Health Records With Unstructured Text to Predict Outcomes With Machine Learning: A Therapeutic Area Fingerprint

    Dec 1, 2022, 00:00

  • EE637 Cost of Follow-Up in Patients With Heterozygous Familial Hypercholesterolemia in Spain: Results From the Reality Study

    Dec 1, 2022, 00:00

  • EE435 First Time Ablation for Patients With Paroxysmal Atrial Fibrillation – Budget Impact of Different Modalities in the Real World

    Dec 1, 2022, 00:00

  • CO133 Analysing Phlebitis Associated With the Use of Peripheral Short Cannulas in an Emergency Department Setting

    Dec 1, 2022, 00:00

  • HPR206 When It Comes to Incentives for Antimicrobial Development – Is a United Front Essential?

    Dec 1, 2022, 00:00

  • EE527 Cost-Effectiveness and Budget Impact Analysis of Remdesivir for the Treatment of COVID-19 in Greece

    Dec 1, 2022, 00:00

  • EE131 Cost-Effectiveness Analysis of Emergency Department-Based HCV Screening and Linkage-to-Care Program

    Dec 1, 2022, 00:00

  • EE10 Cost-Effectiveness of Pembrolizumab Plus Chemotherapies for First-Line Treatment in Locally Advanced Unresectable or Metastatic Triple Negative Breast Cancer (MTNBC) in France

    Dec 1, 2022, 00:00

  • EPH94 Impact of Patient Race on Insurance Payor Switch Rate, Healthcare Resource Utilization, and Cost Among Adult Patients With Schizophrenia in the United States: An Analysis of RWD Insights All-Payer Claims Database

    Dec 1, 2022, 00:00

  • HTA225 A Review of External Evidence Used to Support Survival Extrapolation in Assessments of Cancer Drugs by the National Institute for Health and Care Excellence (NICE)

    Dec 1, 2022, 00:00

  • HPR63 Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines

    Dec 1, 2022, 00:00

  • RWD35 Cost of Illness Study of Acromegaly in Bulgaria - A Real-World Data Analysis

    Dec 1, 2022, 00:00

  • Does the Choice of Cost-Effectiveness Model Approach Matter?

    Dec 1, 2022, 00:00

  • HPR92 Analysis of Nutritional Supplements’ Price Change in Turkiye

    Dec 1, 2022, 00:00

  • EPH50 The Public Health Impact of Routine Vaccination in 16-40-Year-Old Females for the Prevention of Cytomegalovirus and Congenital Cytomegalovirus in the United Kingdom

    Dec 1, 2022, 00:00

  • HTA256 Early Health Technology Assessment of the Lymphocyte Antigen 75 Biomarker for Cutaneous Melanoma

    Dec 1, 2022, 00:00

  • HPR9 Trends in Direct Oral Anticoagulants (DOACS) Use in the Community Setting According to Their Accessibility Under National Health Basket in Israel: Real-World Data

    Dec 1, 2022, 00:00

  • HTA63 Implementation and Application of the Physician Information System (Arztinformationssystem, AIS) in Germany

    Dec 1, 2022, 00:00

  • EPH38 Familial Hypercholesterolemia and Risk of Cardiovascular Disease: A Systematic Literature Review and Meta-Analysis of Observational Studies

    Dec 1, 2022, 00:00

  • MSR4 Data Visualization in Real-World Studies to Aid Understanding and Interpretation

    Dec 1, 2022, 00:00

  • EPH99 Determinants of COVID-19 Vaccination in Hungary, Results of a Large Cross-Sectional Online Survey

    Dec 1, 2022, 00:00

  • HTA38 When and How Does RWE Impact HTA Outcomes in Oncology? A Qualitative Evaluation of Case Studies to Identify Drivers of RWE Acceptance Today and in the Future

    Dec 1, 2022, 00:00

  • EE110 Psychological Impact of COVID-19 and the Economic Burden of Rheumatic and Musculoskeletal Diseases

    Dec 1, 2022, 00:00

  • Editorial Board

    Nov 12, 2022, 08:58

  • Editorial Board

    Nov 3, 2022, 17:50

  • Modeling the Recovery of Elective Waiting Lists Following COVID-19: Scenario Projections for England

    Nov 1, 2022, 00:00

  • Cost-Effectiveness of Care Coordination for Children With Chronic Noncomplex Medical Conditions: Results From a Multicenter Randomized Clinical Trial

    Nov 1, 2022, 00:00

  • Real Option Value: Should We Opt In or Out?

    Nov 1, 2022, 00:00

  • Why We Need a New Outcomes-Based Value Attribution Framework for Combination Regimens in Oncology [Editor's Choice]

    Nov 1, 2022, 00:00

  • The Hip Disability and Osteoarthritis Outcome Score-Physical Function Shortform Does Not Adequately Represent Physical Functioning in Patients Undergoing Total Hip Arthroplasty

    Nov 1, 2022, 00:00

  • Table of Contents

    Nov 1, 2022, 00:00

  • A Simulation-Based Cost-Effectiveness Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Prevention Strategies for Visitors of Healthcare Institutions

    Nov 1, 2022, 00:00

  • Association Between Receipt of Definitive Treatment for Localized Prostate Cancer and Adverse Health Outcomes: A Claims-Based Approach

    Nov 1, 2022, 00:00

  • Measurement Properties of the EQ-5D-Y: A Systematic Review [Editor's Choice]

    Nov 1, 2022, 00:00

  • The Garbage Class Mixed Logit Model: Accounting for Low-Quality Response Patterns in Discrete Choice Experiments

    Nov 1, 2022, 00:00

  • Using Patient-Reported Outcome Measures to Evaluate Care for Patients With Inflammatory Chronic Rheumatic Disease

    Nov 1, 2022, 00:00

  • No Time to Waste: An Appraisal of Value at the End of Life [Editor's Choice]

    Nov 1, 2022, 00:00

  • Copyright/Subscription

    Nov 1, 2022, 00:00

  • The National Hospital Care Survey Is a Unique Source of Data on Rare Diseases

    Nov 1, 2022, 00:00

  • Access to Disease-Modifying Alzheimer’s Therapies: Addressing Possible Challenges Using Innovative Payment Models

    Nov 1, 2022, 00:00

  • A Comprehensive Comparison of Additional Benefit Assessment Methods Applied by Institute for Quality and Efficiency in Health Care and European Society for Medical Oncology for Time-to-Event Endpoints After Significant Phase III Trials—A Si ...

    Nov 1, 2022, 00:00

  • Body of Evidence for Onasemnogene Abeparvovec in Spinal Muscular Atrophy Supports Long-Term Duration of Effect Without Relapse

    Nov 1, 2022, 00:00

  • A Pragmatic Guide to Assessing Real Option Value for Medical Technologies [Editor's Choice]

    Nov 1, 2022, 00:00

  • Editorial Board

    Oct 5, 2022, 08:50

  • How Do Treatment Preferences of Patients With Cancer Compare With Those of Oncologists and Family Members? Evidence From a Discrete Choice Experiment in China

    Oct 1, 2022, 00:00

  • Strengthening the Interface of Evidence-Based Decision Making Across European Regulators and Health Technology Assessment Bodies [Editor's Choice]

    Oct 1, 2022, 00:00

  • Copyright/Subscription

    Oct 1, 2022, 00:00

  • State Laws and Generic Substitution in the Year After New Generic Competition

    Oct 1, 2022, 00:00

  • Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands

    Oct 1, 2022, 00:00

  • Cost-Effectiveness and Economic Burden Analyses on All First-Line Treatments of Chronic Lymphocytic Leukemia

    Oct 1, 2022, 00:00

  • Common Patient-Reported Outcomes Within the Food and Drug Administration Voice of the Patient Reports [Editor's Choice]

    Oct 1, 2022, 00:00

  • Prevalence and Risk Factors of Primary Dysmenorrhea in Students: A Meta-Analysis

    Oct 1, 2022, 00:00

  • A Systematic Review of International Guidance for Self-Report and Proxy Completion of Child-Specific Utility Instruments

    Oct 1, 2022, 00:00

  • Frequently Used Patient-Reported Outcome Measures of General Physical Function Were Highly Correlated With a Multitask Performance Outcome Test Battery

    Oct 1, 2022, 00:00

  • Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated With Uveitis in the United States: A Cost-Effectiveness Analysis

    Oct 1, 2022, 00:00

  • HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force [Editor's Choice]

    Oct 1, 2022, 00:00

  • Value of Nonpharmacological Interventions for People With an Acquired Brain Injury: A Systematic Review of Economic Evaluations

    Oct 1, 2022, 00:00

  • Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing Tools

    Oct 1, 2022, 00:00

  • Moving Beyond Quality-Adjusted Life-Years in Elderly Care: How Can Multicriteria Decision Analysis Complement Cost-Effectiveness Analysis in Local-Level Decision Making

    Oct 1, 2022, 00:00

  • Estimating Quality of Life Decrements in Oncology Using Time to Death

    Oct 1, 2022, 00:00

  • Table of Contents

    Oct 1, 2022, 00:00

  • Where Are Populations Aging Better? A Global Comparison of Healthy Aging Across Organization for Economic Cooperation and Development Countries [Editor's Choice]

    Sep 1, 2022, 00:00

  • Healthcare Costs for Pneumococcal Disease in the Era of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine: A Population-Based Study

    Sep 1, 2022, 00:00

  • How Useful Are Digital Health Terms for Outcomes Research? An ISPOR Special Interest Group Report

    Sep 1, 2022, 00:00

  • Copyright/Subscription

    Sep 1, 2022, 00:00

  • Did the Integrated Urban and Rural Resident Basic Medical Insurance Improve Benefit Equity in China? [Editor's Choice]

    Sep 1, 2022, 00:00

  • Systematic Review of Cost-Utility Analyses That Have Included Carer and Family Member Health-Related Quality of Life

    Sep 1, 2022, 00:00

  • Should We Consider Including a Value for “Hope” as an Additional Benefit Within Health Technology Assessment? [Editor's Choice]

    Sep 1, 2022, 00:00

  • Large-Scale Population-Based Surveys Linked to Administrative Health Databases as a Source of Data on Health Utilities in Australia

    Sep 1, 2022, 00:00

  • Predicting Patient-Level 3-Level Version of EQ-5D Index Scores From a Large International Database Using Machine Learning and Regression Methods

    Sep 1, 2022, 00:00

  • A Scoping Review of Item-Level Missing Data in Within-Trial Cost-Effectiveness Analysis

    Sep 1, 2022, 00:00

  • Value of Triage Treatment Strategies to Distribute Hepatitis C Direct-Acting Antiviral Agents in an Integrated Healthcare System: A Cost-Effectiveness Analysis [Editor's Choice]

    Sep 1, 2022, 00:00

  • Evaluating the Health-Related Quality of Life of the Rare Disease Population in Hong Kong Using EQ-5D 3-Level

    Sep 1, 2022, 00:00

  • Multiple Sclerosis Progressive Courses: A Clinical Cohort Long-Term Disability Progression Study

    Sep 1, 2022, 00:00

  • The Effect of Biosimilar Prescription Targets for Erythropoiesis-Stimulating Agents on the Prescribing Behavior of Physicians in Germany

    Sep 1, 2022, 00:00

  • The Role of Perceived Utility of Full Health in Age Weighting

    Sep 1, 2022, 00:00

  • Patient-Reported Outcome Measures of Quality of Life in People Affected by Diabetic Foot: A Psychometric Systematic Review

    Sep 1, 2022, 00:00

  • Table of Contents

    Sep 1, 2022, 00:00

  • Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes? An ISPOR Special Interest Group Report

    Sep 1, 2022, 00:00

  • Toward System-Wide Implementation of Patient-Reported Outcome Measures: A Framework for Countries, States, and Regions [Editor's Choice]

    Sep 1, 2022, 00:00

  • A Bayesian Approach for Incorporating the EQ-5D Visual Analog Scale When Estimating the Health-Related Quality of Life

    Sep 1, 2022, 00:00

  • Involvement of Patients and Medical Professionals in the Assessment of Relative Effectiveness: A Need for Closer Cooperation

    Sep 1, 2022, 00:00

  • Validation of the Physician’s Global Assessment of Fingernail Psoriasis by Rheumatologists Treating Psoriatic Arthritis

    Sep 1, 2022, 00:00

  • An Investigation of Age-Related Differential Item Functioning in the EQ-5D-5L Using Item Response Theory and Logistic Regression

    Sep 1, 2022, 00:00

  • Editorial Board

    Aug 29, 2022, 08:44

  • Editorial Board

    Aug 3, 2022, 08:59

  • “Bring the Hoses to Where the Fire Is!”: Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs

    Aug 1, 2022, 00:00

  • The Role of Attribute Screening and Choice Set Formation in Health Discrete Choice Experiments: Modeling the Impact of Benefit and Risk Attributes

    Aug 1, 2022, 00:00

  • Defining a Core Data Set for the Economic Evaluation of Precision Oncology

    Aug 1, 2022, 00:00

  • The Impact of Broader Value Elements on Cost-Effectiveness Analysis: Two Case Studies

    Aug 1, 2022, 00:00

  • Public Preferences for Policies to Promote COVID-19 Vaccination Uptake: A Discrete Choice Experiment in The Netherlands [Editor's Choice]

    Aug 1, 2022, 00:00

  • A Systematic Review of Economic Evaluations of COVID-19 Interventions: Considerations of Non-Health Impacts and Distributional Issues

    Aug 1, 2022, 00:00

  • A Discrete Choice Experiment to Elicit General Population Preferences Around the Factors Influencing the Choice to Make Clinical Negligence Claims

    Aug 1, 2022, 00:00

  • Common Sense in Dollars and Cents: Context Matters in Cost-Effectiveness Checklist Evaluations

    Aug 1, 2022, 00:00

  • Author Reply

    Aug 1, 2022, 00:00

  • Real-World Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies During the COVID-19 Pandemic

    Aug 1, 2022, 00:00

  • Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report [Editor's Choice]

    Aug 1, 2022, 00:00

  • The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis

    Aug 1, 2022, 00:00

  • The Impact of Banning Electronic Nicotine Delivery Systems on Combustible Cigarette Sales: Evidence From US State-Level Policies

    Aug 1, 2022, 00:00

  • Table of Contents

    Aug 1, 2022, 00:00

  • Americans’ Health Priorities During the COVID-19 Pandemic

    Aug 1, 2022, 00:00

  • Systematic Review on the Cost-Effectiveness of Seasonal Influenza Vaccines in Older Adults

    Aug 1, 2022, 00:00

  • Preexisting Condition Protections Under the Affordable Care Act: Changes in Insurance Coverage, Premium Contributions, and Out-of-Pocket Spending

    Aug 1, 2022, 00:00

  • Copyright/Subscription

    Aug 1, 2022, 00:00

  • Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials [Editor's Choice]

    Aug 1, 2022, 00:00

  • A National Catalog of Mapped Short-Form Six-Dimension Utility Scores for Chronic Conditions in the United States From 2010 to 2015

    Aug 1, 2022, 00:00

  • Considering Severity in Health Technology Assessment: Can We Do Better?

    Aug 1, 2022, 00:00

  • Brief Cost Analysis of Surgical Personal Protective Equipment During the COVID-19 Pandemic

    Aug 1, 2022, 00:00

  • Value of Reducing Wait Times for Chimeric Antigen Receptor T-Cell Treatment: Evidence From Randomized Controlled Trial Data on Tisagenlecleucel for Diffuse Large B-Cell Lymphoma

    Aug 1, 2022, 00:00

  • Development and Pilot Test of the Registry Evaluation and Quality Standards Tool: An Information Technology–Based Tool to Support and Review Registries [Editor's Choice]

    Aug 1, 2022, 00:00

  • The Sensitivity and Specificity of Repeated and Dominant Choice Tasks in Discrete Choice Experiments

    Aug 1, 2022, 00:00

  • MSR55 Detecting Generalized Pustular Psoriasis Exacerbations in Unstructured Clinical Data Using Deep Neural Networks

    Jul 15, 2022, 18:17

  • HSD131 Alopecia Areata: Trends in Real-World Treatment Patterns in the United States

    Jul 1, 2022, 00:00

  • EE286 Post-Infusion Monitoring Costs By Site of Care Among Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) Who Received Second-LINE Treatment with Lisocabtagene Maraleucel (LISO-CEL) in the Transform Study: A United States ...

    Jul 1, 2022, 00:00

  • EE60 A Review of Analyses Evaluating the Economic Impact of Oral Versus Intravenous Formulations

    Jul 1, 2022, 00:00

  • Cost-Effectiveness of a Core Antigen–Based Rapid Diagnostic Test for Hepatitis C

    Jul 1, 2022, 00:00

  • EE494 Adaptation and Validation of the Nigerian (IGBO) Version of the WHOQOL-OLD Module

    Jul 1, 2022, 00:00

  • EE251 Cost-Effectiveness of an Enhanced Patient Care (EPC) Intervention on Viral Suppression Among Adults Living with HIV in Kenya

    Jul 1, 2022, 00:00

  • HPR63 Logistical and Financial Challenges in the Adoption of CAR-T Therapies: A Narrative Review

    Jul 1, 2022, 00:00

  • CO56 Association of Long-Term Prescription Opioid Use with Advanced Stage Cancer at Diagnosis Among Older Cancer Survivors with Non-Cancer Chronic Pain Conditions (NCPCS)

    Jul 1, 2022, 00:00

  • HPR30 Reimbursement Pathway for Advanced Therapy Medicinal Products in Bulgaria

    Jul 1, 2022, 00:00

  • EE109 A Systematic Review of Cost of Schizophrenia Treatment and the Potential Role of Long Acting Injectables in Easing Economic Burden: A Perspective from 5 Asian Nations

    Jul 1, 2022, 00:00

  • HSD49 Variability in Incidence of Circulatory and Endocrinal Complications Post COVID-19

    Jul 1, 2022, 00:00

  • CO39 Patient Preferences for Attributes of Advanced Migraine Prevention Medications: Findings from a Discrete Choice Experiment

    Jul 1, 2022, 00:00

  • EPH64 Trends in Cancer Mortality in Colombia, 1979-2019

    Jul 1, 2022, 00:00

  • Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set

    Jul 1, 2022, 00:00

  • CO57 Cardiovascular Outcomes in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease Initiating SGLT2 or GLP-1 Medications within Federated-Real-World Data

    Jul 1, 2022, 00:00

  • MSR38 Comparison of Mixture-Cure Model Versus Standard Parametric Survival Model in 1L Diffuse Large B-Cell Lymphoma

    Jul 1, 2022, 00:00

  • HPR50 Life-YEARS Gained with Conditional Reimbursement Access to Innovative Oncological and Hematological Medicines in Finland

    Jul 1, 2022, 00:00

  • EE339 Economic Impact Analysis of the Incorporation of the Elecsys sFlt-1/PIGF Ratio for the Diagnosis and Follow-up of Pregnant Women with Suspected Preeclampsia in Argentina

    Jul 1, 2022, 00:00

  • HTA4 Applicability of Willingness to Pay Thresholds for Oncology Drugs: A Review of Submissions Made to the Canadian Agency for Drugs and Technologies in Health

    Jul 1, 2022, 00:00

  • EE175 Cost Effectiveness of Empagliflozin vs. Ertugliflozin in Patients with Type-2 Diabetes

    Jul 1, 2022, 00:00

  • EPH122 Epidemiological Disease Burden of Female Infertility of Tubal Origin Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • CO54 Medication Regimen Complexity in the Critical Care Unit: Association with Length of Stay, Need for Invasive Mechanical Ventilation, and ICU Mortality

    Jul 1, 2022, 00:00

  • EE290 Direct Medical Cost-Calculator Tool - Economic Burden of Physically Restraining Patients with Agitation and Schizophrenia in Emergency Departments

    Jul 1, 2022, 00:00

  • CO140 Efficacy and Safety of Flavonoids in Adults with Hemorrhoidal Disease: A Systematic Review

    Jul 1, 2022, 00:00

  • CO38 Comparative Safety Assessment of P2Y12 Inhibitors for Secondary Prophylaxis in Acute Coronary Syndrome after Percutaneous Coronary Intervention

    Jul 1, 2022, 00:00

  • CO116 Comparative Effectiveness of a Bilayered Living Cellular Construct and a Split Thickness Skin Graft for the Treatment of Venous Leg Ulcers

    Jul 1, 2022, 00:00

  • EE424 Burden of Disease Estimation for Heart Failure in Colombia

    Jul 1, 2022, 00:00

  • EE154 Burden of Invasive Extraintestinal Pathogenic E. coli Disease Among Older Adult Patients Treated in Hospitals in the US

    Jul 1, 2022, 00:00

  • HSD133 Factors Influencing Selection of First Add-on Disease-Modifying Therapy for Rheumatoid Arthritis after Starting Methotrexate

    Jul 1, 2022, 00:00

  • Award Winners

    Jul 1, 2022, 00:00

  • EE380 Economic Burden of Alzheimer's Disease and Mild Cognitive Decline in Colombia

    Jul 1, 2022, 00:00

  • EE391 Budget Impact of Andexanet ALFA for Gastrointestinal Bleeding Associated with Factor Xa Inhibitors from a US Hospital Perspective

    Jul 1, 2022, 00:00

  • EPH135 The Effect of Lockdown on Reducing Hospitalisations Associated with COVID-19 in Australia

    Jul 1, 2022, 00:00

  • EE276 Patient Characteristics and Healthcare Resource Utilization in Patients with Chronic Inflammatory Demyelinating Polyneuropathy: A Nationwide Population-Based Study in Sweden

    Jul 1, 2022, 00:00

  • HTA65 The Relationship between Globotriaosylceramide (GB3), Globotriaosylsphingosine (LYSO-GB3) and Disease-Related Clinical Events in Patients with Fabry Disease

    Jul 1, 2022, 00:00

  • EPH145 Assessing the Relationship between Heart Disease and Related Comorbidities with Dementia and Alzheimer's Disease

    Jul 1, 2022, 00:00

  • EE377 The Clinical Economic Burden of Treatment Resistant Depression in the GCC: The Kingdom of Saudi Arabia, Kuwait and the United Arab Emirates

    Jul 1, 2022, 00:00

  • MSR46 Visualizing Meaningful Change in Small Sample Sizes

    Jul 1, 2022, 00:00

  • EE213 Cost-Effectiveness Analysis of Axicabtagene Ciloleucel, Brexucabtagene Autoleucel, and Standard of Care for Treatment of Relapsed/Refractory Mantle Cell Lymphoma

    Jul 1, 2022, 00:00

  • EE459 Is Adding Ribociclib to Fulvestrant Cost-Effective in Treating Post-Menopausal Women with HR+/ HER2- Advanced Breast Cancer - a US Payer Perspective Cost-Utility Analysis

    Jul 1, 2022, 00:00

  • CO97 Effectiveness of Letermovir for Cytomegalovirus Prophylaxis in Seropositive Allogeneic Hematopoietic STEM Cell Transplant Recipients: A Global Systematic Review

    Jul 1, 2022, 00:00

  • CO104 Efficacy of Memantine in Preventing Neurocognitive Dysfunction Induced By Radiation Therapy in Patients with Brain Metastases: A Systematic Review of Clinical Trials

    Jul 1, 2022, 00:00

  • HPR57 Health Technology Assessment and the Private Health Insurance Sector in Brazil: A Scoping Review

    Jul 1, 2022, 00:00

  • EE273 Budget Impact of Lixisenatide/Insulin Glargine in the Treatment Oftype 2 Diabetes Mellitus in Guatemala

    Jul 1, 2022, 00:00

  • EE274 Estimated Costs of Adverse Event Management in NSCLC Patients with Epidermal Growth Factor Receptor Exon 20 Insertion Mutations Treated with Amivantamab or Mobocertinib after Progression on Platinum-Based Chemotherapy

    Jul 1, 2022, 00:00

  • EE312 The Economic Burden of Moderate-to-Severe Ulcerative Colitis in the EU5

    Jul 1, 2022, 00:00

  • EE145 Increasing Out-of-Pocket Costs By Stage Among Commercially Insured Patients Diagnosed with Cancer 2016-2020

    Jul 1, 2022, 00:00

  • EPH111 Factors Associated with Cancer Prevention Surgeries for Hereditary Cancer Risk in Arkansas 2013-2018

    Jul 1, 2022, 00:00

  • EE92 Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test for HR+/HER2- Early-Stage Breast Cancer in the US

    Jul 1, 2022, 00:00

  • EE385 Cost and Health Care Resource Utilization (HCRU) in Patients Starting Intravitreal Dexamethasone (DEX) or ANTI-Vascular Endothelial Growth Factor (AVEGF) in Patients with Diabetic Macular Edema (DME)

    Jul 1, 2022, 00:00

  • HPR7 Alignment with Services Providers was the Single Most Challenging Change in the Brazilian National Agency for Private Healthcare System (ANS) Value-Based Healthcare (VBHC) Project.

    Jul 1, 2022, 00:00

  • Do Medicine Shortages Reduce Access and Increase Pharmaceutical Expenditure? A Retrospective Analysis of Switzerland 2015-2020

    Jul 1, 2022, 00:00

  • EE59 Economic Evaluation of Dapagliflozin for the Treatment of Patients with Heart Failure and Reduced Ejection Fraction in Mexico

    Jul 1, 2022, 00:00

  • EE340 A Targeted Literature Review to Inform Future Economic Evaluations of Huntington's Disease

    Jul 1, 2022, 00:00

  • HPR18 The Missing Claimants of 2020: Who Went without Claims in Canada during the First Year of the COVID-19 Pandemic and What Does It Mean for Public and Private Insurers?

    Jul 1, 2022, 00:00

  • HSD28 Cosmetic Dermatology Product Use in Specialty Dermatology Networks

    Jul 1, 2022, 00:00

  • EE46 Venetoclax in Combination with Azacitidine Is Cost-Effective Vs. AZA for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Perspective

    Jul 1, 2022, 00:00

  • EPH89 An Individual Patient Data-Based Meta-Analysis of the Relative Reactogenicity of the Infant Doses of Two Licensed Dtap-Backboned Hexavalent Vaccines

    Jul 1, 2022, 00:00

  • EPH137 Digital Health Solutions for Workers: Engagement with a Digital Tool for Management of SARS-COV-2 Exposure and Infection

    Jul 1, 2022, 00:00

  • EE12 A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab As a First-Line, 12-Month, Fixed Duration Therapy in Chronic Lymphocytic Leukemia (CLL) in Canada

    Jul 1, 2022, 00:00

  • CO30 Clinical Experiences of Type 2 Diabetes (T2DM) Patients Initiating Oral Semaglutide

    Jul 1, 2022, 00:00

  • EE366 Contrasting Three HbA1c Progression Equations Using the IQVIA Core Diabetes Model

    Jul 1, 2022, 00:00

  • EE198 Cost-Effectiveness of Sacubitril/Valsartan for the Treatment of Essential Hypertension in Chinese Setting

    Jul 1, 2022, 00:00

  • EE191 Medical Cost Related to Diabetes Among Middle-Aged and Elderly Individuals Living in China

    Jul 1, 2022, 00:00

  • HSD75 Frequency and Risk Factors for the Development of Drug Related Problems in Hospitalized Patients with Rheumatoid Arthritis

    Jul 1, 2022, 00:00

  • EPH142 Epidemiological Disease Burden and Cost of Illness of Psoriasis in the US

    Jul 1, 2022, 00:00

  • EE393 Incremental Burden of Depression on Direct and Indirect Medical Costs Among Individuals with Irritable Bowel Syndrome in the United States

    Jul 1, 2022, 00:00

  • HSD105 Real-World Treatment Patterns Among Patients with Mycosis Fungoides and Sézary Syndrome in the United States between 2018 and 2020

    Jul 1, 2022, 00:00

  • EPH38 Accessibility of Essential Medicines for Children in Sichuan Province of China: a Cross-Sectional Study

    Jul 1, 2022, 00:00

  • EPH73 Risk Factors for Recurrences of Clostridioides Difficile Infection in the Medicare Population Age 65+ YEARS

    Jul 1, 2022, 00:00

  • EE57 Real-World Reductions in Migraine-Related Health Care Resource Utilization and Costs for Patients Initiating Fremanezumab: A 12-Month Retrospective US Claims Analysis

    Jul 1, 2022, 00:00

  • EE155 The Impact of Value-Based Pricing (VBP) Vs International Reference Pricing (IRP) on Innovative Drugs in the US

    Jul 1, 2022, 00:00

  • EE93 The Budget Impact of Introducing Monocyte Distribution Width (MDW) As a Screening Tool for Sepsis in China

    Jul 1, 2022, 00:00

  • CO51 A Real-World Retrospective Study Evaluating Safety, Effectiveness, and Cost of Intranasal Esketamine for Treatment-Resistant Depression

    Jul 1, 2022, 00:00

  • EE49 Economic Burden of Disease in Patients with Exudative Age-Related Macular Degeneration Using Common Data Model in South Korea

    Jul 1, 2022, 00:00

  • EE376 Indirect Costs of Diabetes Mellitus in Colombia, 1998-2019

    Jul 1, 2022, 00:00

  • EE209 Real-World Opioid Overdose Patient Trends, Costs, and Comorbidities in the United States (2016-2019)

    Jul 1, 2022, 00:00

  • CO83 An Early Look at Literature-Based Survival Trends in Oncology Tumors: Using AI to Synthesize Published Overall Survival Data across Time in Multiple Myeloma (MM), Acute Myeloid Leukemia (AML) and Glioblastoma (GB)

    Jul 1, 2022, 00:00

  • EE396 Healthcare Costs Among Real-World Patients with Recurrent or Metastatic Cervical Cancer (r/mCC) Receiving Second-Line (2L) Treatment

    Jul 1, 2022, 00:00

  • HSD59 Use of a Discrete Choice Experiment to Quantify Palliative Care Experts Preferences for Optimizing Care Delivery to Patients with Life-Limiting Illnesses

    Jul 1, 2022, 00:00

  • EE245 Cost-Effectiveness of Therapeutic Hypothermia for Neonates with Mild Hypoxic-Ischemic Encephalopathy

    Jul 1, 2022, 00:00

  • CO33 Methodological Challenges and Considerations for Decision Makers When Assessing within-Class Comparative Effectiveness and Cost-Effectiveness: The Case of Non-Vitamin K Antagonist Oral Anticoagulants

    Jul 1, 2022, 00:00

  • EE373 Cost-Effectiveness of Statins, Ezetimibe and PCSK9 Inhibitor for Secondary Prevention of Cardiovascular Disease

    Jul 1, 2022, 00:00

  • EE410 Cost-Effectiveness Analysis of Remdesivir for the Treatment of COVID-19 Hospitalized Adults in Three Countries of LATAM: Argentina, Chile, and Colombia

    Jul 1, 2022, 00:00

  • HSD120 Real-World Treatment Patterns Among US Adults with Alopecia Areata: A Retrospective Claims Analysis

    Jul 1, 2022, 00:00

  • CO11 Chemoprevention for Familial Adenomatous Polyposis with Non-Steroid Anti-Inflammatory Drugs: A Systematic Review and Network Meta-Analysis

    Jul 1, 2022, 00:00

  • CO151 Ankle Fracture: Understanding Post-Operative Outcomes in the US Commercially Insured Population

    Jul 1, 2022, 00:00

  • EE224 Comparative Economic Outcomes in Patients with Focal Seizure Initiating Eslicarbazepine Acetate Versus Brivaracetam after Switching from Generic Antiseizure Drug

    Jul 1, 2022, 00:00

  • EE77 Cost-Effectiveness Analysis of Liraglutide for the Treatment of Obesity in Mexico

    Jul 1, 2022, 00:00

  • EE235 Costs of Implementing an Adolescent Transition Package to Facilitate Transition to Adult Care for Adolescents with HIV in Kenya

    Jul 1, 2022, 00:00

  • Recommendations for the Electronic Migration and Implementation of Clinician-Reported Outcome Assessments in Clinical Trials

    Jul 1, 2022, 00:00

  • EE146 Cost and Resource Utilization in Friedreich Ataxia: A Systematic Literature Review

    Jul 1, 2022, 00:00

  • CO78 Efficacy and Safety of Brigatinib in ALK-Positive Non-Small Cell Lung Cancer Treatment: A Systematic Review and Meta-Analysis

    Jul 1, 2022, 00:00
  • «
  • 31 (current)
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • »